This inventor holds 1 USPTO granted patent. Top assignee: Sequus Pharmaceuticals, Inc.. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Josh Gittelman: Innovator in Liposome Technology
Introduction
Josh Gittelman is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of pharmaceutical technology, particularly in the development of liposome compositions for treating bacterial infections. His innovative approach combines advanced materials with established drugs to enhance therapeutic efficacy.
Latest Patents
Gittelman holds a patent for a liposome composition and method for administering a quinolone. This patent describes a liposome composition designed for treating bacterial infections. The composition features liposomes that have a surface coating of hydrophilic polymer chains and an entrapped drug-conjugate composed of ciprofloxacin conjugated to an amino acid. This innovative formulation aims to improve the delivery and effectiveness of the antibiotic.
Career Highlights
Josh Gittelman is associated with Sequus Pharmaceuticals, Inc., where he has been instrumental in advancing liposome technology. His work focuses on creating novel drug delivery systems that can significantly impact patient care. With a patent portfolio that includes 1 patent, Gittelman continues to push the boundaries of pharmaceutical innovation.
Collaborations
Gittelman has collaborated with notable colleagues, including Luke S Guo and Samuel Zalipsky. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of drug delivery systems.
Conclusion
Josh Gittelman's contributions to liposome technology exemplify the innovative spirit of modern pharmaceutical research. His work not only enhances the effectiveness of existing treatments but also paves the way for future advancements in drug delivery systems.